Opioid Stewardship Act

Effective July 1, 2018, all manufacturers, distributors, and importers licensed in New York State (NYS) as of January 1, 2017, must report transaction information for all opioids sold or distributed to or within NYS to the NYS Department of Health's Bureau of Narcotic Enforcement as mandated under the Opioid Stewardship Act (OSA). The Department will calculate ratable shares of an assessment based on the reported data, and will issue invoices for the ratable shares of the assessment to each licensee by October 15, 2018. Payments of the invoices are due on January 1, 2019. The Department will provide guidance on when subsequent reports and payments are due for future years.

Click on the following links for more information and guidance.